Live Breaking News & Updates on Travere Therapeutics Inc

Stay updated with breaking news from Travere therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Travere Therapeutics (NASDAQ:TVTX) Trading Down 6.1%

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) traded down 6.1% during trading on Thursday . The company traded as low as $7.32 and last traded at $7.35. 219,510 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,230,257 shares. The stock had previously closed at […] ....

Canaccord Genuity Group , China Universal Asset Management Co , Dynamic Technology Lab Private Ltd , Nisa Investment Advisors , Entrypoint Capital , Travere Therapeutics Inc , Wells Fargo Company , Travere Therapeutics , Get Free Report , Genuity Group , Point Capital , Investment Advisors , Universal Asset Management , Iga Nephropathy , Travere Therapeutics Daily ,

Travere Therapeutics, Inc. (NASDAQ:TVTX) Stake Boosted by Crestline Management LP

Crestline Management LP raised its position in Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,423 shares of the company’s stock after purchasing an additional 20,002 shares during the quarter. Crestline […] ....

United States , E Fund Management Co , Mirae Asset Global Investments Co , Exchange Commission , Wells Fargo Company , Travere Therapeutics Inc , Fund Management Co , Canaccord Genuity Group , Crestline Management , Travere Therapeutics , Free Report , Retirement System , State Retirement System , Asset Global Investments , Fund Management , Get Free Report , Genuity Group , Wells Fargo , Iga Nephropathy , Travere Therapeutics Daily ,

Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $16.69

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the thirteen research firms that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 12-month price objective […] ....

Dynamic Technology Lab Private Ltd , Nisa Investment Advisors , Travere Therapeutics Company Profile , Canaccord Genuity Group , China Universal Asset Management Co , Entrypoint Capital , Wells Fargo Company , Travere Therapeutics Inc , Travere Therapeutics , Get Free Report , Genuity Group , Wells Fargo , Therapeutics Trading Down , Point Capital , Investment Advisors , Universal Asset Management , Get Free , Iga Nephropathy , Travere Therapeutics Daily ,

GW&K Investment Management LLC Lowers Stock Holdings in Travere Therapeutics, Inc. (NASDAQ:TVTX)

GW&K Investment Management LLC decreased its position in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 5.7% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 318,266 shares of the company’s stock after selling 19,348 shares during the quarter. GW&K Investment Management […] ....

Schonfeld Strategic Advisors , Vanguard Group Inc , Travere Therapeutics Inc , Canaccord Genuity Group , Wells Fargo Company , Vontobel Holding Ltd , Gwk Investment Management , Travere Therapeutics , Free Report , Partners Management , Pension Plan Investment Board , Strategic Advisors , Genuity Group , Get Free Report , Iga Nephropathy , Travere Therapeutics Daily ,